-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.

John A. Herrmann III
Executive Vice President,
Chief Legal Officer,
Business Development,
Strategic Alliances,
Compliance and Corporate Secretary
Chief Legal Officer,
Business Development,
Strategic Alliances,
Compliance and Corporate Secretary
Mr. Herrmann joined Novavax in 2010 and is responsible for managing all of its legal affairs, including its patent portfolio, transactional and contractual matters, and public securities filings, and oversight of corporate and business development activities, along with attending to all the duties of corporate secretary. Mr. Herrmann also works with the senior management team at Novavax to define and develop corporate policies and procedures. Prior to joining Novavax, Mr. Herrmann was general counsel at Ore Pharmaceuticals and deputy general counsel at Gene Logic before it became Ore Pharmaceuticals. Mr. Herrmann previously worked as senior counsel for Celera Genomics and as senior corporate counsel at Baxter Healthcare in its renal division. Mr. Herrmann received a bachelor of arts degree in political science and history from Brown University and a juris doctorate from the University of Illinois.